Overview
In today's highly regulated healthcare environment, pain management toxicology testing and medication monitoring are essential to safe prescribing, regulatory compliance, and patient protection.
Chemisys Laboratories provides comprehensive drug testing services specifically designed for pain management clinics, interventional pain specialists, orthopedic practices, and primary care providers who prescribe controlled medications.
Our advanced toxicology platform delivers accurate, defensible, and clinically actionable results — helping providers monitor compliance, reduce diversion risk, and improve patient outcomes. Pain management drug testing is not about suspicion — it is about safety, documentation, and responsible care.
Why it matters
Clinical value
Confirm medication adherence
Objective verification that patients are taking prescribed medications as directed — protecting both patient and practice.
Detect diversion & misuse
Identify undisclosed substances, non-prescribed drugs, and potential diversion with defensible LC/MS confirmation.
D/L Isomer Reporting
Differentiates D- and L-isomers when clinically appropriate, helping distinguish prescription use from illicit drug use in complex monitoring cases.
Historical reporting
Longitudinal result comparisons and behavioral trend identification support data-driven medication management decisions over time.
Reduce overdose risk
Objective monitoring reduces risk of adverse drug interactions and overdose in patients on controlled medications.
Compliance framework
Clear reporting designed to meet DEA, state medical board, and payer requirements — strengthening documentation for audits and medical record review.
What's included
Capabilities
- Urine Drug Testing (UDT) — customizable panels aligned with prescribing patterns
- Oral fluid drug testing — including remote collection capabilities
- Hair & Nail drug testing for extended detection and diversion investigations
- SecureCollect™ remote witnessed toxicology for telemedicine pain practices
- Validity Plus™ specimen integrity testing — detects dilution, synthetic urine, oxidants, adulterants
- D/L Isomer Reporting — distinguishes prescription use from illicit drug use
- Prescribed opioids and metabolites, benzodiazepines, muscle relaxants, stimulants
- Synthetic opioids including fentanyl, tramadol, and buprenorphine
- Alcohol biomarkers (PEth available)
- Historical reporting for longitudinal compliance tracking
- Panels fully customizable to your practice's formulary and patient population
Applications
Clinical settings we serve
- Pain management clinics and interventional pain specialists
- Orthopedic practices
- Primary care providers prescribing controlled medications
- Chronic pain programs
- Telemedicine-based pain management
Related services
Explore more
PEth Testing
Phosphatidylethanol — a direct biomarker that detects alcohol use up to 2–4 weeks, unaffected by incidental exposure.
Learn moreValidity Plus®
Enhanced specimen validity testing that combines core integrity markers with expanded subversion analytics.
Learn moreToxIQ™
Advanced DNA-verified urine toxicology that confirms every specimen belongs to the individual being tested.
Learn moreAddiction Treatment
Comprehensive toxicology solutions designed specifically for MAT, IOP, residential, sober living, and telehealth programs.
Learn more